GLAXF News and Press, GlaxoSmithKline Plc From 02/12/20

This article is part of a series that provides an ongoing analysis of the changes made to Kenneth Fisher’s 13F stock portfolio on a quarterly basis. It is based on Fisher Asset Management’s regulatory 13F Form filed on 02/12/2020. Please visit our Tracking Kenneth Fisher's Fis...

Musings January 2020 was a tough month for stocks but was especially tough for value and international (especially emerging markets). Source: S&P Dow Jones Source: S&P Dow Jones I hate to dwell on the ugly, but things were really ugly for domestic energy stocks as w...

GlaxoSmithKline plc (GSK) Q4 2019 Results Earnings Conference Call February 05, 2020, 9:00 am ET Company Participants Sarah Elton-Farr - Head of Global Investor Relations Emma Walmsley - Chief Executive Officer Iain Mackay - Chief Financial Officer Hal Barron - Chief Scientific...

The following slide deck was published by GlaxoSmithKline plc in conjunction with their 2019 Q4 earnings Read more ...

Source (Shutterstock/Liya Graphics) Introduction Gilead Sciences ( GILD ) was positioned to be the poster child of Trump's plan to eradicate HIV, as outlined in my previous article . Like almost all outbreaks including the Wuhan coronavirus, the only effective way to complete...

Quick Take Aditx Therapeutics ( ADTX ) has filed to raise $10.5 million in an IPO of its common stock and warrants, according to an S-1 registration statement . The company is a pre-clinical developer of immune suppression drugs to assist in organ transplantation procedures. ADTX is sti...

Actionable Conclusions (1-5): Brokers Predicted 26.35% To 53.85% Net Gains From Top Five Healthcare Sector Dogs By April 2020 One of five top dividend-yielding Healthcare dogs was verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. (...

New York-based pharma giant Pfizer (NYSE: PFE) sold US$5bn of new corporate bonds Monday in five parts, as the company contributes to a groundswell of issuance amid low U.S. interest rates. The senior unsecured deal, comprised of maturities ranging from two- to 30-years, attracted decent dem...

Introduction: GlaxoSmithKline Plc ( OTCPK:GLAXF ) is a global healthcare conglomerate that ranks among the top 10 pharmaceutical companies in the world. Headquartered in the UK, it operates through three business segments namely Pharmaceuticals , Vaccines and Consumer Healthcare . GLA...

With two candidates at Phase 1 of development and others at a preclinical stage, Alector (ALEC) is a name that only long time investors will appreciate. The company could take many years to report revenues from commercialization. The stock price may increase in 2019 as Alector reports new resu...